ClinicalTrials.gov
ClinicalTrials.gov Menu

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Mellitus Patients Not Achieving Glycemic Targets on Basal Insulin With/Without Anti-Hyperglycemic Agents

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02542631
Recruitment Status : Completed
First Posted : September 7, 2015
Last Update Posted : December 14, 2017
Sponsor:
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
Calibra Medical, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 31, 2017
  Actual Study Completion Date : August 31, 2017